Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications posted on February 12, 2025 …Continue Reading about Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications →
Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure posted on October 23, 2024 …Continue Reading about Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure →
Acute effects of cannabigerol on anxiety, stress, and mood: a double‑blind, placebo‑controlled, crossover, field trial posted on July 15, 2024 …Continue Reading about Acute effects of cannabigerol on anxiety, stress, and mood: a double‑blind, placebo‑controlled, crossover, field trial →
Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis posted on March 18, 2024 …Continue Reading about Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis →
When The Pharmacopoeia Fails: Cannabis for Pain posted on January 16, 2023 …Continue Reading about When The Pharmacopoeia Fails: Cannabis for Pain →